Healthcare InnoMatch 2022

To be eligible to participate in this challenge, Start-ups/Small and Medium-sized Enterprises (SMEs) should meet the below criteria:

1. Start-up/SME is a business entity, regardless of its business area, locally or overseas, with revenues below Singapore Dollars One Hundred Million ($100,000,000). This may include research institutions and innovation units of enterprises, if they are subsidiaries.
2. Participating Start-ups/SMEs must not be in negotiation for exit throughout the challenge and test-bedding phase.
3. Start-ups/SMEs are required, in Sponsor’s and/or Organiser’s sole discretion, to provide proof of the above, including but not limited to (i) company registration by submitting a registration certificate issued within the last three (3) months, or ongoing company registration, or any trade registry and proof ensuring the registration of the entity in the relevant country, and (ii) a valid professional insurance policy subscription.
4. Solutions will preferably be at a high level of market readiness. (i.e. Technology Readiness* Level 7 and beyond, Healthcare Translational Level 3 and beyond, or the equivalent).
5. Solutions should seek to deliver improved patient health outcomes (including but not limited to clinical, functional and patient reported outcomes) and patient experience in line with the challenge statements.
6. Solutions may originate from within or outside Singapore, but are required to be test-bedded and evaluated in one of the three healthcare clusters in Singapore.
7. Solutions with the relevant safety or regulatory approvals will be preferred.
8. Proposals that have prior demonstration of clinical efficacy or have been previously validated would be preferred. Proposals in early research studies, early minimally viable products or solutions that are still in development phase will not be accepted.
9. Proposals relating to operational processes that do not have a direct impact to patient outcomes will not be accepted.